News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Stephen V Liu: ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study
Photo of Solange Peters taken from Stephen V Liu/Twitter
Oct 24, 2023, 13:45

Stephen V Liu: ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study

Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University, on X/Twitter:

“ESMO23 – Dr. Solange Peters presents the PERLA randomized phase II study comparing two PD-1 inhibitors in NSCLC. Dostarlimab + chemotherapy versus pembrolizumab + chemotherapy. Some differences in dostarlimab binding – will that translate to an OS difference?”

Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study

Source: Stephen V Liu/Twitter

cancer Dostarlimab ESMO OncoDaily Oncology pembrolizumab Solange Peters Stephen V Liu
Special Coverage
Blog
Jun 30, 2025, 16:51
Alessio Cortellini Highlights Christian Rolfo's Lecture on Liquid Biopsy in NSCLC
Blog
Jun 30, 2025, 16:43
Enrique Soto: Great attendance at the Geriatric Oncology session in MASCC2025
Science
Jun 30, 2025, 16:39
ESGO Shared an Article on Peritonectomy Procedures for Peritoneal Surface Malignancies
Blog
Jun 30, 2025, 16:33
Nina Niu Sanford: New GI pathology 101 series With Suntrea Hammer - Coming Soon
Blog
Jun 30, 2025, 16:15
Darcy Burbage: A Great Session to End MASCC 2025 Annual Meeting
Blog
Jun 30, 2025, 15:49
Aaron Goodman: Transplant and Cell Therapy has Arrived in the State of Nevada
Blog
Jun 30, 2025, 15:34
Sumanta Pal: New On the Edge of Breakthrough Podcast Episode is Out
Blog
Jun 30, 2025, 15:23
Jasmine Kamboj Reflects on Toni Choueiri’s Insights in Empowering Oncologists Podcast Episode
Blog
Jun 30, 2025, 15:15
Small Steps, Big Living: Why What You Don’t Do Matters - Sami Mansfield
Blog
Jun 30, 2025, 15:03
Pratiek Paatil Questions the Increasing Incidence of TP53 Mutations in Cancer Patients
Science
Jun 30, 2025, 15:02
Arndt Vogel: KRAS Variants were Linked to Poor Prognosis in Biliary Tract Cancers
Blog
Jun 30, 2025, 14:52
European Cancer Organisation - Registration is Open for Community 365 Roundtable: Addressing the Challenges of Women and Cancer